Flash FinanceUS
Market closed S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Vericel (VCEL)

Vericel expects 2025 revenue of $276 million and net income for second straight year

Positive Impact 3 of 5 earnings Written later

Vericel released preliminary, unaudited 2025 results on January 13, 2026, ahead of its January 14 presentation at the J.P. Morgan Healthcare Conference. The company expects total net revenue of about $276 million, GAAP net income for a second consecutive year, and $200 million in cash and investments with no debt. The figures are subject to change and may differ materially from the audited statements.

Key points

  • Total net revenue expected at approximately $276 million, including MACI net revenue of $239.5 million and Burn Care net revenue of $36.5 million
  • Gross margin expected at 74% and adjusted EBITDA margin at 26%
  • GAAP net income profitability expected for the second consecutive year
  • Fourth-quarter total revenue and MACI revenue each grew 23%; PricewaterhouseCoopers has not audited the preliminary data

The filing

CompanyVericel (VCEL)
Form8-K, current report
Filed with the SECJan 13, 2026, 9:11 AM ET
Accession number0001140361-26-001060

Items reported: 2.02 Results of Operations7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:49 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on January 13, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.